“Bimekizumab Efficacy in Patients with Moderate to Severe Plaque Psoriasis and Hypertension, Elevated Body Mass Index, or Hyperglycemia: Results Through 3 years of Treatment in 5 Phase 3/3b Trials”, J of Skin, vol. 8, no. 1, p. s308, Jan. 2024, doi: 10.25251/skin.8.supp.308.